OrbiMed’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
OrbiMed's LTGO Position: Q3 2026 in Review
OrbiMed opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 1,675,316 shares worth $28M. The stake represents 0.51% of the portfolio and ranks #47 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- OrbiMed held 1,675,316 shares of Latigo Biotherapeutics worth $28M as of Q3 2026.
- Latigo Biotherapeutics was a new OrbiMed position in Q3 2026.
- Latigo Biotherapeutics made up 0.51% of OrbiMed's portfolio in Q3 2026, its #47 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.